GlassScriptPhysician profile
Woojin Kim
NPI 1134387111
$7,981.42
in general payments reported to CMS, 2019-2025
15 companies · $2,198 in 2025
The $2,198 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $164 · 2021: $3,803 · 2022: $255 · 2023: $591 · 2024: $686 · 2025: $2,198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,864 · Food and Beverage: $1,424 · Consulting Fee: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,863.91 |
| Food and Beverage | $1,423.72 |
| Consulting Fee | $187.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,930.89 | 2019-2025 | Apollo Esg Nxt System, Exalt Model D, Apollo Esg System |
| Hyperfine Operations, INC. | $2,582.50 | 2021-2023 | Swoop |
| Creo Medical INC. | $611.99 | 2021-2024 | Speedboat, Speedboat Ultraslim (Sb1l) |
| Olympus Corporation of The Americas | $591.96 | 2025 | Disposable Distal Attachment, Single Use Electrosurgical Knife Kd-655 |
| Micro-Tech Endoscopy USA, INC. | $414.61 | 2024 | |
| Ipsen Biopharmaceuticals, INC | $287.62 | 2019-2020 | |
| Celltrion, INC. | $150.00 | 2025 | |
| Alexion Pharmaceuticals, INC. | $125.00 | 2021 | |
| Aimmune Therapeutics, INC. | $111.65 | 2025 | Zenpep |
| Lucid Diagnostics INC. | $60.86 | 2022 | |
| Conmed Corporation | $40.21 | 2023 | Conmed Biliary, Conmed Generators |
| Erbe USA INC | $36.22 | 2019 | |
| Cook Medical LLC | $18.42 | 2019 | |
| Braintree Laboratories, INC. | $13.14 | 2021 | |
| Apollo Endosurgery US INC | $6.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Woojin Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.